Vaccination of stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells.

MLA

Maio, Michele, et al. “Vaccination of Stage IV Patients with Allogeneic IL-4- or IL-2-Gene-Transduced Melanoma Cells Generates Functional Antibodies against Vaccinating and Autologous Melanoma Cells.” Cancer Immunology, Immunotherapy : CII, vol. 51, no. 1, Mar. 2002, pp. 9–14. EBSCOhost, https://doi.org/10.1007/s00262-001-0249-z.

APA

Maio, M., Fonsatti, E., Lamaj, E., Altomonte, M., Cattarossi, I., Santantonio, C., Melani, C., Belli, F., Arienti, F., Colombo, M. P., & Parmiani, G. (2002). Vaccination of stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells. Cancer Immunology, Immunotherapy : CII, 51(1), 9–14. https://doi.org/10.1007/s00262-001-0249-z

Chicago

Maio, Michele, Ester Fonsatti, Elda Lamaj, Maresa Altomonte, Ilaria Cattarossi, Cristina Santantonio, Cecilia Melani, et al. 2002. “Vaccination of Stage IV Patients with Allogeneic IL-4- or IL-2-Gene-Transduced Melanoma Cells Generates Functional Antibodies against Vaccinating and Autologous Melanoma Cells.” Cancer Immunology, Immunotherapy : CII 51 (1): 9–14. doi:10.1007/s00262-001-0249-z.